Showing 1 - 10 of 68,324
We study the Medicare Part D prescription drug insurance program as a bellwether for designs of private, non-mandatory health insurance markets, focusing on the ability of consumers to evaluate and optimize their choices of plans. Our analysis of administrative data on medical claims in Medicare...
Persistent link: https://www.econbiz.de/10009571572
We study the Medicare Part D prescription drug insurance program as a bellwether for designs of private, non-mandatory health insurance markets that control adverse selection and assure adequate access and coverage. The focus of this paper is on the ability of consumers to evaluate and optimize...
Persistent link: https://www.econbiz.de/10009666978
We study the Medicare Part D prescription drug insurance program as a bellwether for designs of private, non-mandatory health insurance markets, focusing on the ability of consumers to evaluate and optimize their choices of plans. Our analysis of administrative data on medical claims in Medicare...
Persistent link: https://www.econbiz.de/10013104980
We study the Medicare Part D prescription drug insurance program as a bellwether for designs of private, non-mandatory health insurance markets, focusing on the ability of consumers to evaluate and optimize their choices of plans. Our analysis of administrative data on medical claims in Medicare...
Persistent link: https://www.econbiz.de/10012460495
Dieser Band der Bad Orber Gespräche 2016 enthält die erweiterten Referate eines interdisziplinären Workshops zum Thema "Neuerungen im Krankenhaus- und Arzneimittelbereich zwischen Bedarf und Finanzierung". Vertreter des Deutschen Bundestages, des Gemeinsamen Bundesausschusses, des...
Persistent link: https://www.econbiz.de/10011929966
Motivated by the medical literature findings that physicians are inertial, we seek to understand (1) whether physicians exhibit structural persistence in drug choice (structural persistence occurs when the drug chosen for a patient depends structurally on the drug previously prescribed by the...
Persistent link: https://www.econbiz.de/10012756795
Persistent link: https://www.econbiz.de/10003385083
Persistent link: https://www.econbiz.de/10011491588
Persistent link: https://www.econbiz.de/10011493976
"Private insurance for prescription drugs is characterized by two regimes: flat copayments and variable co-insurance. We develop a simple model to show that patient compliance is lower under coinsurance due to uncertainty in cost-sharing. Empirically, we derive comparable models for compliance...
Persistent link: https://www.econbiz.de/10002225444